Stock SNT SYNTARA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Syntara Limited

Equities

SNT

AU0000312480

End-of-day quote Australian S.E.
Other stock markets
 23:00:00 19/05/2024 BST 		5-day change 1st Jan Change
0.018 AUD -10.00% Intraday chart for Syntara Limited +5.88% -10.00%
04-30 Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024
04-10 Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024
Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment
MT
Syntara Limited Reports Earnings Results for the Half Year Ended December 31, 2023
CI
Syntara to Begin Phase Two Study for SNT-5505 Combination Therapy Later in 2024 After Government Grant
MT
Transcript : Syntara Limited - Shareholder/Analyst Call
Syntara Opens Up to AU$2 Million Share Purchase Plan
MT
Syntara Starts Dosing Patients in Phase Two Trial of Drug Candidate
MT
Syntara Receives AU$5.2 Million R&D Tax Rebate
MT
Pharmaxis Doses First Patient in Phase Two Sleep Trial
MT
University of Birmingham : Promising target for liver disease treatments identified; Inhibiting a protein involved in liver inflammation has the potential to reduce or stop fibrosis in patients with non-alcoholic steatohepatitis, trial finds
AQ
Pharmaxis Ltd Reports Earnings Results for the First Quarter Ended September 30, 2023
CI
Transcript : Pharmaxis Ltd, Q1 2024 Earnings Call, Oct 31, 2023
Pharmaxis Sells Mannitol Business; Shares Fall 3%
MT
Arna Pharma Pty Ltd completed the acquisition of Mannitol respiratory business of Pharmaxis.
CI
BTC Health Arm to Continue Distributing Bronchitol, Aridol in Australia
MT
Pharmaxis to focus on clinical-stage drug development
AQ
Pharmaxis to Change Name Amid Restructure, Appoints Chair
MT
Transcript : Pharmaxis Ltd - Special Call
Arna Pharma Pty Ltd entered into definitive agreement to acquire Mannitol respiratory business of Pharmaxis.
CI
Australian Bourse Halts Trading in Pharmaxis’ Securities
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SNT Stock
  4. News Syntara Limited